Regulatory documentation enquiries
A regulatory-documentation enquiry to GALVANTA COMPANY LIMITED should identify the requesting organisation, jurisdiction, exact subject and purpose of the requested record.
Technical documents
Identify the document or evidence required.
Product, manufacturing and control information
Distinguish product identity from the scientific and technical information required for a dossier, including a complete product specification beyond website names, strengths and images.
Artwork records
Identify the product, market, version and any evidence of authority approval for packaging text beyond its appearance in an image or document.
Dossier changes
State whether the question concerns a proposed change, a submitted variation or an authority decision, identifying the evidence for the particular stage.
Authority questions
Identify the authority reference and the organisation responsible for the response.
Market-specific records
Keep the legal entity, site, product, strength, presentation and country distinct, identifying the permission for each combination separately.
Current status and contact
The company’s current pharmaceutical status is set out in Regulatory information.
Email [email protected]. Do not send confidential authority correspondence without confirming that disclosure is permitted.
Prerequisites
The company holds no pharmaceutical manufacturing licence or GMP certificate. Any proposed documentation undertaking requires a defined scope, authority to act, evidenced capability, applicable authorisations and a separate agreement. It does not guarantee an authority’s decision. Possession of a product dossier, authority to act for another applicant and submission of an application require separate evidence. The existence, ownership and releasability of a requested document require separate assessment.